NUFORMIX PLC
NFX | IL
Overview
Corporate Details
- ISIN(s):
- GB00BYW79Y38
- LEI:
- 2138003XG3H3I2J3BJ24
- Country:
- United Kingdom
- Address:
- 6TH FLOOR, EC3V 0HR LONDON
- Website:
- https://www.nuformix.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Nuformix PLC develops novel pharmaceutical products using proprietary cocrystal technology, focusing on oncology and fibrosis treatments in the UK.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-29 08:00 |
Regulatory News Service
Confirmation of European ODD for NXP002
|
English | 13.6 KB | |
| 2025-05-28 11:28 |
Prospectus
Nuformix plc - Single prospectus
|
English | 866.5 KB | |
| 2025-05-23 14:19 |
Prospectus
Prospectus
|
English | 866.5 KB | |
| 2025-05-23 14:08 |
Prospectus
Publication of a Prospectus
|
English | 13.3 KB | |
| 2025-02-28 13:30 |
Regulatory News Service
Total Voting Rights
|
English | 9.3 KB | |
| 2025-02-14 15:18 |
Annual Report
Posting of Annual Report and Notice of AGM
|
English | 8.4 KB | |
| 2025-01-30 08:00 |
Regulatory News Service
£168,750 Placing
|
English | 13.1 KB | |
| 2025-01-29 08:00 |
Annual Report
Annual Results for period ended 30 September 2024
|
English | 414.7 KB | |
| 2025-01-28 08:00 |
Regulatory News Service
NXP002 ODD Application Submitted
|
English | 11.4 KB | |
| 2025-01-13 08:00 |
Business and Financial Review
NXP002 Orphan Drug Designation Draft Application
|
English | 9.6 KB | |
| 2024-11-29 18:00 |
Regulatory News Service
Total Voting Rights
|
English | 9.1 KB | |
| 2024-11-05 15:25 |
Prospectus
Director/PDMR Dealings
|
English | 39.9 KB | |
| 2024-11-04 11:17 |
Declaration of Voting Results & Voting Rights Announcements
Result of General Meeting
|
English | 21.2 KB | |
| 2024-10-18 11:34 |
Prospectus
Nuformix plc - Single prospectus
|
English | 1.6 MB | |
| 2024-10-16 14:37 |
Prospectus
Publication of Prospectus & Notice of GM
|
English | 16.4 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |